Conference abstract · 7 Nov 2016
Conference abstractPublished 7 Nov 2016
Pentagenic haplotype-related cholesterolemic phenotype in Alzheimer’s disease
EuroEspes Biomedical Research Center, Spain
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Hypercholesterolemia is a major risk factor for cardiovascular disorders, stroke and dementia (Alzheimer’s disease, vascular dementia). Many different genes are involved in lipid metabolism responsible for the cholesterolemic phenotype. Genes potentially associated with pathogenic lipid metabolism dysfunction in dementia include the following: APOB (OMIM 107730; rs693 [7545C>T], APOEC3 (OMIM 107720; rs5128 [3175G>C, S1/S2], APOE (OMIM 107741; rs429358/rs7412 [112T>C/158T>C, E2, E3, E4], CETP (OMIM 118470; rs708272 [+279G>A, B1/B2] and LPL (OMIM 609708; rs328 [1421C>G, S474X]. In a selected group of 933 Alzheimer’s disease (AD) patients, we constructed a pentagenic haplotype integrating all possible variants of the APOE+APOB+EPOC3+CETP+LPL genes and identified 111 haplotypes (H) with differential basal cholesterol (CHO) levels. About 75% of these haplotypes in the AD population have a frequency below 1%, 10% have a frequency between 1% and 2%, 8% have a frequency between 2% and 5% and only 4% of the haplotypes are present in more than 5% of AD patients. The haplotypes most frequently found are H55 (33-CT-CC-AG-CC (8.79%), H58 (33-CT-CC-GG-CC) and H37 (33-CC-CC-AG-CC) (7.07%). Haplotypes H104 (44-CC-CC-AA-CC) (0.11%), H110 (44-TT-CC-AG-CG) (0.11%) and H98 (34-TT-CC-AA-CG) (0.11%) showed the highest CHO levels and the lowest levels corresponded to haplotypes H26 (23-TT-CG-AG-CC) (0.11%), H8 (23-CC-CG-AG-CC) (0.21%), H50 (33-CC-GG-AG-CC) (0.21%) and H63 (33-CT-CG-AA-GG) (0.11%). These haplotypes have been used for pharmacogenetic studies in hypercholesterolemic patients with AD.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Review article · 22 Jan 2018
The Correlation between Genotype and Phenotype of Alzheimer's Disease
Conference abstract · 20 Dec 2016
A small peptide derived from a neuronal cell cycle like kinase activator, P35, is a possible therapeutic candidate to reduce the phenotypes of neurodegenerative disorders like Parkinsons and Alzheimers diseases
Conference abstract · 5 Dec 2016
A small peptide derived from a neuronal cell cycle like kinase activator, P35, is a possible therapeutic candidate to reduce the phenotypes of neurodegenerative disorders like Parkinson’s and Alzheimer’s diseases
Conference abstract · 2016
A novel therapeutic approach to ameliorate the Parkinsion s and Alzheimer s Disease phenotypes
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Ramon Cacabelos”
